Bradykinin B1 receptor (B1R) targeting peptides and compounds are radiolabelled with radioisotopes that are suitable for imaging and/or radiotherapy. The radiolabelled peptides and compounds have utility in imaging tissues expressing or overexpressing B1R and/or treating diseases or conditions in which B1R is expressed or overexpressed, including cancer.
缓激肽 B1 受体(B1R)靶向肽和化合物被放射性同位素标记,适用于成像和/或放射治疗。放射性标记的肽和化合物可用于表达或过度表达 B1R 的组织的成像和/或治疗 B1R 表达或过度表达的疾病或病症,包括癌症。